Simple Summary The Epstein–Barr virus (EBV) contributes to different forms of human
cancer, including a subset of classical Hodgkin lymphoma (cHL), a B-cell lymphoma with …

Introduction Epstein− Barr virus (EBV) contributes significantly to the development and
occurrence of B-cell lymphomas. However, the association between EBV infection status …

Background and Aims The prevalence and prognostic significance of Epstein-Barr virus
(EBV) infection in classical Hodgkin's lymphomas (cHLs) remain elusive. To examine the …

The Epstein–Barr virus (EBV), Kaposi sarcoma herpesvirus (KSHV) and human T-
lymphotropic virus (HTLV-1) are lymphomagenic viruses with region-specific induced …

It has been estimated that 15%-20% of human cancers are attributable to infections, mostly
by carcinogenic viruses. The incidence varies worldwide, with a majority affecting …

Background Cancer/testis antigens are considered potential targets for immunotherapy due
to their tumor-associated expression pattern. Although recent studies have demonstrated …

The treatment of childhood cancer requires complex, longitudinal, multidisciplinary care
delivered by a dedicated team of providers in addition to reliable infrastructural support …

Objective: Although classical Hodgkin lymphoma (c HL) has a relatively good prognosis, it
also entails different treatment responses and involves patients who have different clinical …

Epstein–Barr virus (EBV) is a human oncogenic herpesvirus associated with lymphoma and
nasopharyngeal carcinoma. Because the susceptible hosts of EB virus are limited to human …

Hodgkin lymphoma (HL) is an uncommon malignancy usually limited to the lymph nodes
and lymphatic system while extranodal involvement is much less common than in non …